Our results corroborate well with a previous study that inferred that Gli1 activated platelet-derived growth factor receptor (PDGFR α) leading to the activation of RAS/ERK pathway in basal cell carcinoma [27]. Here, GLI1 is linked to basal cell carcinoma.